Afya (NASDAQ:AFYA) Downgraded to “Buy” Rating by Wall Street Zen

Wall Street Zen cut shares of Afya (NASDAQ:AFYA) from a strong-buy rating to a buy rating in a research note published on Saturday.

AFYA has been the subject of a number of other research reports. Morgan Stanley set a $17.50 target price on shares of Afya and gave the stock an “overweight” rating in a research report on Wednesday, August 6th. Weiss Ratings reissued a “hold (c)” rating on shares of Afya in a research report on Wednesday, October 8th. UBS Group raised shares of Afya from a “neutral” rating to a “buy” rating and cut their target price for the stock from $19.50 to $19.00 in a research report on Monday, September 8th. Citigroup raised shares of Afya from a “sell” rating to a “neutral” rating and cut their target price for the stock from $16.00 to $14.00 in a research report on Tuesday, July 29th. Finally, JPMorgan Chase & Co. raised shares of Afya from a “neutral” rating to an “overweight” rating and boosted their target price for the stock from $23.50 to $24.50 in a research report on Monday, September 8th. Three research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $18.20.

Afya Stock Up 0.9%

AFYA stock opened at $14.90 on Friday. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.22. Afya has a 1 year low of $13.47 and a 1 year high of $19.90. The company has a fifty day simple moving average of $15.27 and a 200 day simple moving average of $16.64. The firm has a market cap of $1.40 billion, a PE ratio of 11.29, a PEG ratio of 0.45 and a beta of 0.61.

Institutional Trading of Afya

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AFYA. Carrera Capital Advisors bought a new stake in Afya in the second quarter valued at about $1,750,000. Swedbank AB bought a new stake in Afya in the third quarter valued at about $1,092,000. Jump Financial LLC bought a new stake in Afya in the second quarter valued at about $731,000. Goldman Sachs Group Inc. increased its stake in Afya by 167.3% in the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after acquiring an additional 28,226 shares during the period. Finally, Cerity Partners LLC bought a new stake in Afya in the first quarter valued at about $476,000. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.